ACCESSION: MSBNK-SMB_Measured-HSA033P0184001
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.04.01, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 21
COMMENT: RAW_SPEC {'C8neg_3853': {'bp': 3675.0, 'sum': 5830.0}, 'D168neg_3920': {'bp': 3475.0, 'sum': 5054.0}, 'C8neg_3840': {'bp': 2524.0, 'sum': 4246.0}, 'C5neg_3983': {'bp': 2203.0, 'sum': 3455.0}, 'D207neg_4017': {'bp': 2129.0, 'sum': 2994.0}, 'C8neg_3890': {'bp': 1632.0, 'sum': 2400.0}, 'D142neg_3965': {'bp': 1525.0, 'sum': 2346.0}, 'D178neg_3861': {'bp': 1409.0, 'sum': 2013.0}, 'D83neg_4172': {'bp': 1342.0, 'sum': 2008.0}, 'D117neg_4086': {'bp': 1299.0, 'sum': 2104.0}, 'D83neg_4135': {'bp': 1293.0, 'sum': 2019.0}, 'D122neg_4149': {'bp': 1290.0, 'sum': 2219.0}, 'C10neg_3842': {'bp': 1188.0, 'sum': 1599.0}, 'D142neg_3957': {'bp': 976.0, 'sum': 1594.0}, 'C2neg_3955': {'bp': 875.0, 'sum': 1608.0}, 'D203neg_3816': {'bp': 801.0, 'sum': 1206.0}, 'C5neg_3943': {'bp': 686.0, 'sum': 1022.0}, 'D168neg_3911': {'bp': 654.0, 'sum': 1494.0}, 'C10neg_3834': {'bp': 560.0, 'sum': 749.0}, 'D124neg_3908': {'bp': 458.0, 'sum': 752.0}, 'D124neg_3901': {'bp': 255.0, 'sum': 402.0}}
COMMENT: RETENTION_TIME_STDEV 0.028
COMMENT: PRECURSOR_M/Z_RAW 184.071582
COMMENT: PRECURSOR_M/Z_STDEV 0.000442
COMMENT: PRECURSOR_IN_MS1 mz 184.071666; int 43.690; delta(ppm) -0.767092
COMMENT: PROPOSED_CHARGE_STATE -1; mz 185.075119; int 3.354; cor 0.896
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M+Na-2H; mz 206.053621; int 1.352; cor 0.893
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 5.743; C7H11N3O3; [M-H]1; delta(ppm) -5.743494
COMMENT: PROPOSED_MF MS-FINDER 4.347; C7H11N3O3; [M-H]-; delta(ppm) -5.773843
COMMENT: PROPOSED_MF MS-FINDER 2.913; C5H16NO4P; [M-H]-; delta(ppm) -14.747155
COMMENT: PROPOSED_MF SIRIUS5_Sirius 16.172; C7H11N3O3; [M-H]-; delta(ppm) -5.773843
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H11N3O3; [M-H]-; delta(ppm) -5.773843
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.534; C7H11N3O3; [M-H]-; delta(ppm) -5.773843
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.598; C5H10F3N3O; [M-H]-; delta(ppm) 7.510547
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.519; C5H9N6O2; [M-H]-; delta(ppm) 1.520369
COMMENT: PROPOSED_MF SIRIUS6_Sirius 13.380; C4H13N2O6; [M-H]-; delta(ppm) 8.786166
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.766; C3H14N4O3P; [M-H]-; delta(ppm) -7.453074
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.156; C3H7N9O; [M-H]-; delta(ppm) 8.814686
COMMENT: PROPOSED_MF SIRIUS6_Sirius 9.897; C2H12ClN7O; [M-H]-; delta(ppm) -115345.736327
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.973; CH12N7O2P; [M-H]-; delta(ppm) -0.158888
COMMENT: PROPOSED_MF SIRIUS6_Sirius -5.437; H11N9OS; [M-H]-; delta(ppm) -9.499510
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H11N3O3; [M-H]-; delta(ppm) -5.773843
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.787; BDIXWZLLNILION-UHFFFAOYSA-N; [M-H]-; O=C1NC=C(NCCCO)C(=O)N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.667; XFNJVKMNNVCYEK-UHFFFAOYSA-N; [M-H]-; NC(=O)CC1=CC=CC2=C1C=CC=C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.450; LBQFDLRXNAORNL-UHFFFAOYSA-N; [M-H]-; O=C(N)CN1C(=O)CCC1C(=O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.191; SKIVBBIKOOPRPR-UHFFFAOYNA-N; [M-H]-; CC(NC1=NC(=O)CN1C)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; MFAQZCMCEFTNIJ-UHFFFAOYSA-N; [M-H]-; OC1=CC=CN=C1C=2C=CC(=CC2)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.388; KPQZUUQMTUIKBP-UHFFFAOYNA-N; [M-H]-; 1-(2-methyl-5-nitro-1-imidazolyl)-2-propanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.337; SKIVBBIKOOPRPR-UHFFFAOYNA-N; [M-H]-; (S)-N-(4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)alanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.254; DUOHVNSMLSPTMI-UHFFFAOYSA-N; [M-H]-; Ternidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.202; LRAQTHRXQNHAAH-UHFFFAOYNA-N; [M-H]-; Ipronidazole-hydroxy
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.165; BDIXWZLLNILION-UHFFFAOYSA-N; [M-H]-; 5-[(3-hydroxypropyl)amino]-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.138; MECFJRKHUMMFGS-HNBBVXEKNA-N; [M-H]-; UNPD197249
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.053; LBQFDLRXNAORNL-UHFFFAOYSA-N; [M-H]-; 1-(carbamoylmethyl)-5-oxopyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; SKIVBBIKOOPRPR-UHFFFAOYNA-N; [M-H]-; (S)-N-(4,5-Dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)alanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.714; LBQFDLRXNAORNL-UHFFFAOYSA-N; [M-H]-; 1-(carbamoylmethyl)-5-oxopyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.501; BDIXWZLLNILION-UHFFFAOYSA-N; [M-H]-; 5-[(3-hydroxypropyl)amino]-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.475; KPQZUUQMTUIKBP-UHFFFAOYNA-N; [M-H]-; 1-(2-methyl-5-nitro-1-imidazolyl)-2-propanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.405; DUOHVNSMLSPTMI-UHFFFAOYSA-N; [M-H]-; Ternidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.405; LRAQTHRXQNHAAH-UHFFFAOYNA-N; [M-H]-; Ipronidazole-hydroxy
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.210; MECFJRKHUMMFGS-HNBBVXEKNA-N; [M-H]-; UNPD197249
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.475; KPQZUUQMTUIKBP-UHFFFAOYSA-N; [M-H]-; 1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; SKIVBBIKOOPRPR-UHFFFAOYSA-N; [M-H]-; 2-[(1-methyl-4-oxoimidazolidin-2-ylidene)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.166; FXIFXKWJMGBHHO-YFKPBYRVSA-N; [M-H]-; (2S)-2-amino-3-(2-methyl-3-oxo-1H-pyrazol-4-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.158; PWFDXPAAUFJSSA-UHFFFAOYSA-N; [M-H]-; 2-(4-ethyl-3-methyl-5-oxo-1,2,4-triazol-1-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.157; BIZCLBYCUPABAD-WEVVVXLNSA-N; [M-H]-; 2-[(2E)-2-carbamoyliminopyrrolidin-1-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.956; LLGHIXICGJDRMU-RXMQYKEDSA-N; [M-H]-; methyl (2R)-2-amino-3-(3-oxo-1,2-dihydropyrazol-4-yl)propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.945; NOQCJLXBVDNVFG-UHFFFAOYSA-N; [M-H]-; 2-(5,5-dimethyl-2,4-dioxoimidazolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; MXGRRFUCRGENRR-UHFFFAOYSA-N; [M-H]-; methyl 2-[4-(1-hydroxyethyl)triazol-1-yl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; CVWNVAUOPWCYSN-UHFFFAOYSA-N; [M-H]-; methyl 2-[4-(2-hydroxyethyl)triazol-1-yl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; YZEWEIJSLLACIN-UHFFFAOYSA-N; [M-H]-; 6-amino-1-(2-methoxyethyl)pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.812; FATLUVZBHLRIQC-UHFFFAOYSA-N; [M-H]-; N'-(2-hydroxyethyl)-5-methyl-1,2-oxazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.809; XCAPETXPNIXJQN-UHFFFAOYSA-N; [M-H]-; 3-[3-(dimethylamino)-1,2,4-oxadiazol-5-yl]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.809; CXOIHWNPMZMTAO-UHFFFAOYSA-N; [M-H]-; ethyl 2-[3-(aminomethyl)-1,2,4-oxadiazol-5-yl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.802; DUOHVNSMLSPTMI-UHFFFAOYSA-N; [M-H]-; 3-(2-methyl-5-nitroimidazol-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.746; DTHPMNDYKOSVFR-UHFFFAOYSA-N; [M-H]-; 2-(1-methyl-5-nitroimidazol-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.675; ODSRAEZVAFOUOH-UHFFFAOYSA-N; [M-H]-; ethyl 5-(hydroxymethyl)-2-methyl-1,2,4-triazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.669; HVFBJWHGPCLJTR-UHFFFAOYSA-N; [M-H]-; ethyl 5-(hydroxymethyl)-1-methyl-1,2,4-triazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.666; UOCITRKYCKNSJL-UHFFFAOYSA-N; [M-H]-; ethyl 5-(methoxymethyl)-1H-1,2,4-triazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.666; PEHOOILBFVEUEV-SCSAIBSYSA-N; [M-H]-; ethyl 5-[(1R)-1-hydroxyethyl]-1H-1,2,4-triazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.623; OGKCPJNRQBTBPF-UHFFFAOYSA-N; [M-H]-; 2,4,6-trimethoxypyrimidin-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.615; ABGJIKXMJUSARA-UHFFFAOYSA-N; [M-H]-; 2-(5-ethyl-2-nitroimidazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.592; HRSGYKLMWRWVCM-UHFFFAOYSA-N; [M-H]-; 1-methyl-4-nitro-3-propan-2-yloxypyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.553; WLOXDXOPKNBBFP-UHFFFAOYSA-N; [M-H]-; 2-(3-methyl-2-nitroimidazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.539; WKWQIMRIQQDCEM-UHFFFAOYSA-N; [M-H]-; 1-(3-methyl-2-nitroimidazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.504; REWQNYFPXZTNHQ-UHFFFAOYSA-N; [M-H]-; tert-butyl N-(1,2,4-oxadiazol-3-yl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.497; PWADXPITHGKDSY; [M-H]-; Cyclo(-Gly-Gln)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.135; LBQFDLRXNAORNL; [M-H]-; 1-(2-amino-2-oxoethyl)-5-oxoprolinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.278; SKIVBBIKOOPRPR; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -279.699; BDIXWZLLNILION; [M-H]-; 5-[(3-hydroxypropyl)amino]pyrimidine-2,4(1H,3H)-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -307.890; DUOHVNSMLSPTMI; [M-H]-; Ternidazol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.518; LRAQTHRXQNHAAH; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -336.014; JRXLILGOSVVPCW; [M-H]-; 1-(2-methyl-4-nitroimidazol-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -346.835; KPQZUUQMTUIKBP; [M-H]-; Flagentyl
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -353.026; ABGJIKXMJUSARA; [M-H]-; 5-Ethyl-2-nitroimidazole-1-ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -378.597; HRSGYKLMWRWVCM; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -390.461; DTHPMNDYKOSVFR; [M-H]-; Ipronidazole-OH
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -418.805; KSSIVZJLHJBIHN; [M-H]-; N-Diazoacetyl-D,L-alanine ethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -420.409; FATLUVZBHLRIQC; [M-H]-; N''-(2-Hydroxyethyl)-5-methyl-3-isoxazolecarbohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -421.365; MECFJRKHUMMFGS; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -421.946; WKWQIMRIQQDCEM; [M-H]-; alpha,1-Dimethyl-2-nitroimidazole-5-ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -440.960; WLOXDXOPKNBBFP; [M-H]-; Imidazole-5-methanol,.alpha.,1-trimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.177; PWADXPITHGKDSY; [M-H]-; Cyclo(-Gly-Gln)
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -185.098; BWZRMBUNAOJHOY; [M-H]-; {(2S)-2-[(1S)-1-Aminoethyl]-5-oxo-2,5-dihydro-1H-imidazol-1-YL}acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -185.817; NOQCJLXBVDNVFG; [M-H]-; 2-(5,5-Dimethyl-2,4-dioxoimidazolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.910; DUOHVNSMLSPTMI; [M-H]-; 1,1,2,2,3,3-Hexadeuterio-3-(2-methyl-5-nitroimidazol-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -229.067; SKIVBBIKOOPRPR; [M-H]-; 2-[(4-hydroxy-1-methyl-2,5-dihydro-1H-imidazol-2-ylidene)amino]propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -235.306; JJYCGTAEWKCZIP; [M-H]-; 5-[(2-hydroxyethyl)amino]-6-methylpyrimidine-2,4(1H,3H)-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -247.633; JRXLILGOSVVPCW; [M-H]-; alpha,2-Dimethyl-4-nitro-1H-imidazole-1-ethanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -247.633; KPQZUUQMTUIKBP; [M-H]-; Secnidazole-d6
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -248.106; ABGJIKXMJUSARA; [M-H]-; Imidazole-1-ethanol, 5-ethyl-2-nitro-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -257.221; PWADXPITHGKDSY; [M-H]-; (S)-3-(3,6-Dioxopiperazin-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -271.112; CVWNVAUOPWCYSN; [M-H]-; methyl 2-[4-(2-hydroxyethyl)-1H-1,2,3-triazol-1-yl]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.079; BWZRMBUNAOJHOY; [M-H]-; {(2S)-2-[(1S)-1-Aminoethyl]-5-oxo-2,5-dihydro-1H-imidazol-1-YL}acetic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H10N3O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 Âµm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 4.302
MS$FOCUSED_ION: PRECURSOR_M/Z 184.071702
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-9000000000-27d1f7b4b3f3a7adc536
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  41.9975457 999.0000 41.997541 3.7621 0.00 1.0000 20 f{C1N1O1}/-23.61ppm,p-C6H10N2O2
  58.0285667 100.0077 58.028547 8.8405 35.54 0.7805 17 f{C2H4N1O1}/-21.90ppm,p-C5H6N2O2
  74.0232144 266.5743 74.023165 8.5244 98.95 0.7881 20 f{C2H4N1O2}/-20.77ppm,p-C5H6N2O1
  113.0708124 98.7626 113.070769 7.7739 33.17 0.9384 20 f{C5H9N2O1}/-10.83ppm,p-C2H1N1O2
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  41.997546 999.00 999
  58.028567 100.01 100
  74.023214 266.57 266
  113.070812 98.76 98
//
